Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.073 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |